|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C12N 15/13 | (2006.01) | ||
| C12N 5/12 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2769992 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14162081.5 |
| Date of filing the European patent application | 2007-10-02 | |
| (97) | Date of publication of the European application | 2014-08-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation | 2021-04-12 |
| (30) | Number | Date | Country code |
| 848694 P | 2006-10-02 | US | |
| 957738 P | 2007-08-24 | US |
| (72) |
Stevens, Sean, US
Huang, Tammy T., US
Martin, Joel H., US
Fairhurst, Jeanette L., US
Rafique, Ashique, US
Torres, Marcela, US
Pobursky, Kevin J., US
Leidich, Raymond W., US
Windsor, Joan A., US
Mikulka, Warren R., US
Ahrens, Diana M., US
Shi, Ergang, US
Papadopoulos, Nicholas J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Didelio afiniškumo žmogaus antikūnai, atpažįstantys žmogaus IL-4 receptorių |
| High affinity human antibodies to human IL-4 receptor |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 19 | 347.00 EUR |
| 2026-10-02 |